miércoles, 16 de agosto de 2023

FDA Approves New Initial Treatment Option for Some Metastatic Prostate Cancers

https://www.cancer.gov/news-events/cancer-currents-blog/2023/fda-talazoparib-enzalutamide-prostate-cancer?cid=eb_govdel_cancerinfo

No hay comentarios:

Publicar un comentario